Efficacy and safety of sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction according to background MRA therapy: a pooled analysis of PARAGLIDE-HF and PARAGON-HF
Prognostic significance of left atrial diameter to left ventricular diastolic diameter ratio in patients with heart failure with preserved ejection fraction
Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: analysis of safety outcomes of the REBALANCE-HF randomized trial